CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 80 enrolled
Drug / intervention
borage/echium oil combination +2 moredrug
Likely dose
borage/echium oil combination 0.85gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01145066
NCT01145066Phase 2Completed
CompareCT.gov

Modulation of Biomarkers and Gene Expression by Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects.

Wake Forest University Health Sciences·interventional·Posted Jun 16, 2010·Updated Jul 18, 2019

In Brief

A Phase 2 clinical trial evaluating borage/echium oil combination, fish oil, and 1 other intervention for Diabetes and Metabolic Syndrome x. Completed, enrolled 80 participants across 1 site.

Detailed Summary

This study will compare how well a combination of borage and echium oils will reduce inflammation compared to fish oils and placebo oil in subjects that are diabetic or have metabolic syndrome.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes, Metabolic Syndrome x
CountriesUnited States
CollaboratorsBrigham and Women's Hospital

Timeline

Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 16, 2010
Enrollment StartMay 1, 2009
Primary CompletionMar 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 16.0 years ago

Interventions

borage/echium oil combinationdrug

borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA

fish oildietary

1.6g/day EPA and 1.08g/day DHA

corn oildietary

contains 4.5 g/day linoleic acid